Charity News from Sunday, Jun. 1, 2003Genetic alterations help predict severe side effects related to irinotecanThe University of Chicago Medical Center | The presence of specific gene alterations can help doctors predict which colorectal cancer patients are likely to experience severe side effects from the new chemotherapy drug irinotecan, new research shows. Survey on Iraqi Children Launched International Rescue Committee | The International Rescue Committee is taking part in a comprehensive assessment of the needs of children and the risks they are facing in post-conflict Iraq. MRI May Help Find Missed Breast Cancers in High Risk Women Memorial Sloan-Kettering Cancer Center | New research presented today at the annual meeting of the American Society of Clinical Oncology finds that Magnetic Resonance Imaging (MRI) is a highly sensitive screening tool that may detect breast cancers missed by mammograms. Targeted Lung Cancer Treatment Causes Tumor Regression in Some Patients Memorial Sloan-Kettering Cancer Center | A new study suggests that a drug called erlotinib (TarcevaTM) has promising activity in patients with bronchioloalveolar cell carcinoma (BAC), a type of non-small cell lung cancer generally considered to be resistant to chemotherapy. Jewelry industry raises $850,000 for St. Jude St. Jude Children's Research Hospital (ALSAC) | On June 1, the Jewelers Charity Fund for Children presented St. Jude Children's Research Hospital with a check for $850,000. This money is part of a $2 million commitment to fund a chair position in the Cell and Gene Therapy Program at St. Jude. River Bend Research Products Partners With America's Second Harvest To Fight Child Hunger In Recognition Of National Hunger Awareness Day America's Second Harvest | Today, River Bend Research Media Productions announced it is joining forces with America's Second Harvest, the largest domestic hunger-relief charity in the United States, in recognition of National Hunger Awareness Day (NHAD). Reduced Intensity Bone Marrow Transplantation Offers New Hope for Older Leukemia Patients City of Hope | Bone marrow transplantation (BMT) is an effective treatment for leukemia and other life-threatening hematologic diseases, but oncologists have traditionally used it only in younger patients because of its potential toxic side effects.
|
|
